By Linda A. Johnson

Johnson & Johnson said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.

The affected products, packaged in aerosol cans, are Aveeno Protect + Refresh aerosol sunscreen, and four Neutrogena sunscreen versions: Beach Defense aerosol sunscreen, CoolDry Sport aerosol sunscreen, Invisible Daily Defense aerosol sunscreen and UltraSheer aerosol sunscreen.

The recall includes all can sizes and all levels of sun protection factor, or SPF. The products were distributed nationwide through retailers.

The health care giant said the benzene was found after testing by the company and an independent laboratory. It is investigating how the chemical got into the products.

J&J said it’s working to get all lots of the five products removed from store shelves. It urged consumers to stop using the sunscreens immediately and said customers can get a refund by calling J&J’s Consumer Care Center at 1-800-458-1673. More information is available at the websites for Neutrogena and Aveeno.

J&J said in a statement that “use of these products would not be expected to cause adverse health consequences" and that it voluntarily decided to recall them "out of an abundance of caution.” The statement added that people should use an alternate sunscreen to protect themselves from the skin cancer melanoma.

Benzene is a highly flammable, widely used chemical that's present throughout the environment. It can cause cancer with repeated exposure at high enough levels. It also can damage the immune system and prevent cells from functioning properly, according to the U.S. Centers for Disease Control and Prevention.

The chemical's effects vary by whether a person accidentally inhales or ingests it or gets it on skin and clothing. Symptoms range from dizziness and irregular heartbeat to convulsions and, at very high levels, death.

J&J, which is based in New Brunswick, New Jersey, said it has notified the Food and Drug Administration of the recall.

Share:
More In Business
Macy's Rejects $5.8B Takeover Bid From Investors
Macy’s is rejecting a $5.8 billion takeover offer from investment firms Arkhouse Management and Brigade Capital Management, saying they didn’t provide a viable financing plan. The firms offered $21 per share for the stock they don’t already own.
Tech Stocks Still on the Rise
Pete Najarian, co-owner of Market Rebellion, shares what sectors he's watching as the S&P 500 and Dow notch historic highs.
Ford Cuts Production of F-150 Lightning Electric Truck
Ford says it’s reducing production of the F-150 Lightning electric pickup vehicle as it adjusts to weaker-than-expected electric vehicle sales growth. The automaker said about 1,400 workers will be impacted by the move.
Load More